This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Genzyme Corporation. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Inventor Catherine Wilson
Introduction
Catherine Wilson is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of Pompe disease. With a total of 2 patents, her work has the potential to impact many lives.
Latest Patents
Catherine's latest patents include innovative methods for treating late-onset Pompe disease. The first patent provides methods of treating late-onset Pompe disease (LOPD) using a pharmaceutical composition comprising an oligosaccharide-acid α-glucosidase (GAA) conjugate, such as avalglucosidase alfa. The second patent focuses on treating infantile-onset Pompe disease (IOPD) with similar pharmaceutical compositions and formulations of the oligosaccharide-GAA conjugates.
Career Highlights
Catherine Wilson is currently associated with Genzyme Corporation, where she continues to advance her research and development efforts. Her work is crucial in the ongoing fight against Pompe disease, showcasing her dedication to improving patient outcomes.
Collaborations
Catherine collaborates with talented individuals such as Kristina An Haack and Patrick Finn, contributing to a dynamic research environment that fosters innovation.
Conclusion
Catherine Wilson's contributions to the field of medicine through her patents and collaborations highlight her role as a leading inventor in the treatment of Pompe disease. Her work exemplifies the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile